Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis
Miloslav Kverka(Czech Academy of Sciences, Institute of Microbiology), Chris J. Mulder(Amsterdam University Medical Centers), Milan Lukáš(Charles University), Helena Tlaskalová‐Hogenová(Czech Academy of Sciences, Institute of Microbiology), P Roßmann(Czech Academy of Sciences), Bindia Jharap(Meander Medisch Centrum), René Vos(Amsterdam UMC Location Vrije Universiteit Amsterdam), Nanne K.H. de Boer, Klára Klimešová(Czech Academy of Sciences), Adriaan A. van Bodegraven(Maastricht University Medical Centre)
Cited by 15
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten‐related disorders
|United European Gastroenterology Journal|2019|987
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724